Pharmacologic Class A-Z Index
What are Pharmacological Classes?
A pharmacologic class is a group of drugs that share scientifically documented properties. The pharmacologic class of each product is determined by any of the following attributes of the drug:
- 1. Mechanism of action (MOA) - Pharmacologic action at the receptor, membrane, or tissue level
- 2. Physiologic effect (PE) - Pharmacologic effect at the organ, system, or whole body level
- 3. Chemical structure (CS)
The pharmacologic class of a drug is important information for health care professionals because it provides a reference about what to expect from a drug and how it relates to other therapeutic options. This information could also help reduce the risk of duplicative therapy and drug interactions, in cases of drug overdose it provides important treatment information.
The following table is an alphabetical listing of all pharmacologic class available in the NDC dataset.
Pharmacologic Class | Pharmacologic Name | Pharmacologic Class | Number of Products |
---|---|---|---|
N0000175809 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor | [EPC] | 22 |
N0000175836 | 5-alpha Reductase Inhibitor | [EPC] | 94 |
N0000000126 | 5-alpha Reductase Inhibitors | [MoA] | 94 |
N0000175956 | 5-Lipoxygenase Inhibitor | [EPC] | 6 |
N0000175955 | 5-Lipoxygenase Inhibitors | [MoA] | 6 |
N0000000183 | Acetyl Aldehyde Dehydrogenase Inhibitors | [MoA] | 9 |
N0000175771 | Acetylcholine Release Inhibitor | [EPC] | 33 |
N0000175770 | Acetylcholine Release Inhibitors | [MoA] | 33 |
N0000175833 | Acidifying Activity | [MoA] | 404 |
N0000180850 | Actinomycin | [EPC] | 7 |
N0000183364 | Actively Acquired Immunity | [PE] | 162 |
N0000178375 | Adenosine Receptor Agonist | [EPC] | 181 |
N0000175788 | Adenosine Receptor Agonists | [MoA] | 194 |
N0000193913 | Adenosine Triphosphate-Citrate Lyase Inhibitor | [EPC] | 2 |
N0000193914 | Adenosine Triphosphate-Citrate Lyase Inhibitors | [MoA] | 2 |
N0000175928 | Adrenal Steroid Synthesis Inhibitor | [EPC] | 1 |
N0000175921 | Adrenal Steroid Synthesis Inhibitors | [MoA] | 1 |
N0000000122 | Adrenergic Agonists | [MoA] | 3 |
N0000009917 | Adrenergic alpha1-Agonists | [MoA] | 1996 |
N0000009918 | Adrenergic alpha2-Agonists | [MoA] | 510 |
N0000000209 | Adrenergic alpha-Agonists | [MoA] | 854 |
N0000000099 | Adrenergic alpha-Antagonists | [MoA] | 625 |
N0000009923 | Adrenergic beta1-Antagonists | [MoA] | 213 |
N0000009922 | Adrenergic beta2-Agonists | [MoA] | 272 |
N0000009924 | Adrenergic beta2-Antagonists | [MoA] | 213 |
N0000185007 | Adrenergic beta3-Agonists | [MoA] | 8 |
N0000000245 | Adrenergic beta-Agonists | [MoA] | 405 |
N0000000161 | Adrenergic beta-Antagonists | [MoA] | 1401 |
N0000175883 | Adrenergic Receptor Agonist | [EPC] | 3 |
M0000499 | Adrenocorticotropic Hormone | [CS] | 84 |
N0000175941 | Adrenocorticotropic Hormone | [EPC] | 84 |
N0000175679 | Aldehyde Dehydrogenase Inhibitor | [EPC] | 9 |
N0000175557 | Aldosterone Antagonist | [EPC] | 219 |
N0000011310 | Aldosterone Antagonists | [MoA] | 219 |
M0000712 | Alkaline Phosphatase | [CS] | 4 |
N0000009986 | Alkalinizing Activity | [MoA] | 108 |
N0000193949 | Alkaloid | [EPC] | 39 |
M0000713 | Alkaloids | [CS] | 39 |
N0000000236 | Alkylating Activity | [MoA] | 234 |
N0000175558 | Alkylating Drug | [EPC] | 234 |
M0000728 | Allergens | [CS] | 6982 |
N0000171131 | Allergens | [Chemical/Ingredient] | 36 |
N0000184318 | Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy | [EPC] | 1 |
N0000184319 | Allogeneic Cultured Cell Scaffold | [EPC] | 2 |
M0000751 | Allylamine | [CS] | 84 |
N0000175874 | Allylamine Antifungal | [EPC] | 84 |
N0000000166 | alpha Glucosidase Inhibitors | [MoA] | 38 |
N0000186105 | alpha-1 Adrenergic Agonist | [EPC] | 1995 |
N0000175552 | alpha-Adrenergic Agonist | [EPC] | 854 |
N0000175553 | alpha-Adrenergic Blocker | [EPC] | 625 |
N0000175559 | alpha-Glucosidase Inhibitor | [EPC] | 38 |
M0000794 | alpha-Glucosidases | [CS] | 8 |
N0000187052 | alpha-Particle Emitting Activity | [MoA] | 1 |
N0000175801 | Aluminum Complex | [EPC] | 52 |
N0000008294 | Alveolar Surface Tension Reduction | [PE] | 2 |
N0000175682 | Amide Local Anesthetic | [EPC] | 1563 |
M0000897 | Amides | [CS] | 1546 |
N0000175780 | Amino Acid | [EPC] | 58 |
N0000175797 | Amino Acid Hypertonic Solution | [EPC] | 8 |
M0000922 | Amino Acids | [CS] | 66 |
M0370111 | Amino Acids, Aromatic | [CS] | 151 |
N0000175477 | Aminoglycoside Antibacterial | [EPC] | 506 |
M0000946 | Aminoglycosides | [CS] | 506 |
N0000180855 | Aminoketone | [EPC] | 331 |
N0000175781 | Aminosalicylate | [EPC] | 89 |
M0000971 | Aminosalicylic Acids | [CS] | 89 |
N0000175806 | Ammonium Ion Binding Activity | [MoA] | 132 |
N0000020016 | AMPA Receptor Antagonists | [MoA] | 10 |
N0000175480 | Amphenicol-class Antibacterial | [EPC] | 5 |
N0000175479 | Amphenicols | [EXT] | 5 |
N0000175425 | Amphetamine Anorectic | [EPC] | 3 |
M0001015 | Amphetamines | [CS] | 3 |
N0000193951 | Amyloid Beta-directed Antibody | [EPC] | 4 |
N0000193950 | Amyloid Beta-directed Antibody Interactions | [MoA] | 4 |
N0000175452 | Analogs/Derivatives | [Chemical/Ingredient] | 158 |
N0000175824 | Androgen | [EPC] | 177 |
N0000000146 | Androgen Receptor Agonists | [MoA] | 177 |
N0000000243 | Androgen Receptor Antagonists | [MoA] | 20 |
N0000175560 | Androgen Receptor Inhibitor | [EPC] | 20 |
M0001109 | Androstanes | [CS] | 177 |
N0000193915 | Angiopoietin-like 3 Inhibitor | [EPC] | 2 |
N0000193916 | Angiopoietin-like 3 Inhibitors | [MoA] | 2 |
N0000000070 | Angiotensin 2 Receptor Antagonists | [MoA] | 1146 |
N0000175561 | Angiotensin 2 Receptor Blocker | [EPC] | 1150 |
N0000180999 | Angiotensin 2 Type 1 Receptor Antagonists | [MoA] | 4 |
N0000175562 | Angiotensin Converting Enzyme Inhibitor | [EPC] | 998 |
N0000000181 | Angiotensin-converting Enzyme Inhibitors | [MoA] | 998 |
M0370530 | Animal Fur | [CS] | 33 |
M0001287 | Ant Venoms | [CS] | 19 |
N0000175481 | Anthelmintic | [EPC] | 23 |
M0001301 | Anthelmintics | [CS] | 1 |
N0000175414 | Anthracycline Topoisomerase Inhibitor | [EPC] | 88 |
M0028312 | Anthracyclines | [CS] | 88 |
N0000192703 | Anthrax Protective Antigen-directed Antibody | [EPC] | 2 |
N0000192702 | Anthrax Protective Antigen-directed Antibody Interactions | [MoA] | 2 |
N0000170890 | Anthrax Vaccines | [Chemical/Ingredient] | 2 |
N0000175427 | Anti-anginal | [EPC] | 55 |
N0000175426 | Antiarrhythmic | [EPC] | 1717 |
M0001352 | Antibodies | [CS] | 2 |
M0001357 | Antibodies, Monoclonal | [CS] | 76 |
M0556300 | Antibodies, Monoclonal, Humanized | [CS] | 5 |
N0000020023 | Antibody-Surface Protein Interactions | [MoA] | 5 |
N0000175574 | Anticholinergic | [EPC] | 636 |
N0000175980 | Anti-coagulant | [EPC] | 457 |
N0000178374 | Antidiarrheal | [EPC] | 44 |
N0000175429 | Antidote | [EPC] | 45 |
N0000175961 | Antidote for Acetaminophen Overdose | [EPC] | 35 |
N0000178372 | Antiemetic | [EPC] | 199 |
N0000175753 | Anti-epileptic Agent | [EPC] | 1196 |
N0000175634 | Antifibrinolytic Agent | [EPC] | 88 |
N0000184008 | Antigen Neutralization | [MoA] | 51 |
M0001408 | Antigens, Bacterial | [CS] | 14 |
M0419493 | Antigens, Dermatophagoides | [CS] | 32 |
M0001418 | Antigens, Fungal | [CS] | 1 |
N0000175750 | Antihistamine | [EPC] | 771 |
N0000190852 | Antihypoglycemic Agent | [EPC] | 24 |
N0000175794 | Anti-IgE | [EPC] | 4 |
M0001335 | Anti-Inflammatory Agents, Non-Steroidal | [CS] | 4064 |
N0000190851 | Antileishmanial | [EPC] | 1 |
N0000175482 | Antimalarial | [EPC] | 209 |
N0000180853 | Antimetabolite | [EPC] | 28 |
N0000175613 | Antimetabolite Immunosuppressant | [EPC] | 106 |
N0000175483 | Antimycobacterial | [EPC] | 42 |
N0000175484 | Antiparasitic | [EPC] | 18 |
N0000175485 | Antiprotozoal | [EPC] | 48 |
N0000175713 | Antirheumatic Agent | [EPC] | 102 |
N0000191626 | Antisense Oligonucleotide | [EPC] | 5 |
N0000175486 | Antiseptic | [EPC] | 1 |
M0001511 | Antitoxins | [CS] | 1 |
N0000184162 | Antivenin | [EPC] | 3 |
N0000170922 | Antivenins | [Chemical/Ingredient] | 1 |
M0001517 | Antivenins | [CS] | 1 |
N0000175372 | Appetite Suppression | [PE] | 207 |
N0000175563 | Aromatase Inhibitor | [EPC] | 63 |
N0000175080 | Aromatase Inhibitors | [MoA] | 63 |
N0000193220 | Aromatic Amino Acid | [EPC] | 151 |
N0000175379 | Arteriolar Vasodilation | [PE] | 406 |
N0000175564 | Arteriolar Vasodilator | [EPC] | 406 |
M0001797 | Ascorbic Acid | [CS] | 189 |
M0001815 | Asparaginase | [CS] | 3 |
N0000175669 | Asparagine-specific Enzyme | [EPC] | 3 |
N0000175430 | Atypical Antipsychotic | [EPC] | 1491 |
N0000184997 | Autologous Cellular Immunotherapy | [EPC] | 1 |
N0000184317 | Autologous Cultured Cell | [EPC] | 1 |
N0000175641 | Autonomic Ganglionic Blocker | [EPC] | 2 |
N0000175487 | Azole Antifungal | [EPC] | 830 |
M0002083 | Azoles | [CS] | 829 |
N0000182636 | B Lymphocyte Stimulator-directed Antibody Interactions | [MoA] | 3 |
N0000182637 | B Lymphocyte Stimulator-specific Inhibitor | [EPC] | 3 |
N0000184141 | Bacterial Neurotoxin Neutralization | [MoA] | 1 |
N0000175693 | Barbiturate | [EPC] | 100 |
M0002177 | Barbiturates | [CS] | 100 |
M0002239 | BCG Vaccine | [CS] | 2 |
N0000192515 | BCL-2 Inhibitor | [EPC] | 3 |
N0000020009 | Bcr-Abl Tyrosine Kinase Inhibitors | [MoA] | 46 |
M0002274 | Bee Venoms | [CS] | 400 |
N0000175694 | Benzodiazepine | [EPC] | 891 |
N0000175680 | Benzodiazepine Antagonist | [EPC] | 18 |
M0002356 | Benzodiazepines | [CS] | 891 |
N0000175740 | Benzothiazole | [EPC] | 9 |
M0483511 | Benzothiazoles | [CS] | 9 |
N0000175875 | Benzylamine Antifungal | [EPC] | 20 |
M0002392 | Benzylamines | [CS] | 20 |
N0000175930 | beta Lactamase Inhibitor | [EPC] | 353 |
N0000000202 | beta Lactamase Inhibitors | [MoA] | 353 |
N0000175779 | beta2-Adrenergic Agonist | [EPC] | 272 |
N0000185008 | beta3-Adrenergic Agonist | [EPC] | 8 |
N0000175555 | beta-Adrenergic Agonist | [EPC] | 405 |
N0000175556 | beta-Adrenergic Blocker | [EPC] | 1535 |
N0000175565 | Biguanide | [EPC] | 539 |
M0002471 | Biguanides | [CS] | 539 |
N0000175802 | Bile Acid | [EPC] | 58 |
N0000180292 | Bile Acid Sequestrant | [EPC] | 77 |
M0002475 | Bile Acids and Salts | [CS] | 58 |
N0000193845 | Bile Salt Export Pump Inhibitors | [MoA] | 6 |
N0000175365 | Bile-acid Binding Activity | [MoA] | 77 |
M0002611 | Bismuth | [CS] | 237 |
N0000180183 | Bismuth | [EPC] | 237 |
N0000193989 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager | [EPC] | 1 |
N0000175579 | Bisphosphonate | [EPC] | 135 |
N0000184168 | Blood Coagulation Factor | [EPC] | 944 |
M0002684 | Blood Coagulation Factors | [CS] | 34 |
N0000175895 | Blood Viscosity Reducer | [EPC] | 7 |
M0002832 | Boron Compounds | [CS] | 13 |
N0000182965 | Bradykinin B2 Receptor Antagonist | [EPC] | 11 |
N0000182964 | Bradykinin B2 Receptor Antagonists | [MoA] | 11 |
N0000190113 | Breast Cancer Resistance Protein Inhibitors | [MoA] | 121 |
N0000193934 | Bruton's Tyrosine Kinase Inhibitors | [MoA] | 1 |
N0000175457 | Calcineurin Inhibitor Immunosuppressant | [EPC] | 153 |
N0000175458 | Calcineurin Inhibitors | [MoA] | 153 |
M0003145 | Calcitonin | [CS] | 8 |
N0000175942 | Calcitonin | [EPC] | 8 |
N0000193952 | Calcitonin Gene-related Peptide Antagonist | [EPC] | 1 |
N0000193953 | Calcitonin Gene-related Peptide Antagonists | [MoA] | 1 |
N0000193917 | Calcitonin Gene-related Peptide Receptor Antagonist | [EPC] | 9 |
N0000193918 | Calcitonin Gene-related Peptide Receptor Antagonists | [MoA] | 9 |
M0003153 | Calcium | [CS] | 936 |
N0000175901 | Calcium | [EPC] | 16 |
N0000000069 | Calcium Channel Antagonists | [MoA] | 1177 |
N0000175566 | Calcium Channel Blocker | [EPC] | 782 |
N0000175089 | Calcium Chelating Activity | [MoA] | 284 |
N0000175902 | Calcium-sensing Receptor Agonist | [EPC] | 61 |
N0000175835 | Calculi Dissolution Agent | [EPC] | 1368 |
N0000175782 | Cannabinoid | [EPC] | 34 |
M0003267 | Cannabinoids | [CS] | 37 |
N0000184144 | Carbamoyl Phosphate Synthetase 1 Activator | [EPC] | 4 |
N0000184143 | Carbamoyl Phosphate Synthetase 1 Activators | [MoA] | 4 |
M0024174 | Carbapenems | [CS] | 64 |
M0003375 | Carbon Radioisotopes | [CS] | 1 |
N0000175517 | Carbonic Anhydrase Inhibitor | [EPC] | 120 |
N0000000235 | Carbonic Anhydrase Inhibitors | [MoA] | 166 |
N0000184013 | Carboxypeptidase | [EPC] | 1 |
M0003411 | Carboxypeptidases | [CS] | 1 |
N0000175568 | Cardiac Glycoside | [EPC] | 60 |
M0003451 | Cardiac Glycosides | [CS] | 60 |
N0000008330 | Cardiac Rhythm Alteration | [PE] | 79 |
M0003493 | Carnitine | [CS] | 25 |
N0000175903 | Carnitine Analog | [EPC] | 25 |
M0003590 | Caseins | [CS] | 4 |
N0000175756 | Catechol O-Methyltransferase Inhibitors | [MoA] | 43 |
N0000175570 | Catecholamine | [EPC] | 433 |
N0000175569 | Catecholamine Synthesis Inhibitor | [EPC] | 3 |
N0000175361 | Catecholamine Synthesis Inhibitors | [MoA] | 3 |
M0003647 | Catecholamines | [CS] | 487 |
N0000175757 | Catechol-O-Methyltransferase Inhibitor | [EPC] | 43 |
M0003682 | Cations, Divalent | [CS] | 921 |
N0000175572 | CCR5 Co-receptor Antagonist | [EPC] | 12 |
N0000193864 | CD123 Interaction | [EPC] | 1 |
N0000193865 | CD123 Interactions | [MoA] | 1 |
N0000193544 | CD19 Receptor Interactions | [MoA] | 3 |
N0000193546 | CD19-directed Chimeric Antigen Receptor | [EPC] | 3 |
M000615883 | CD19-specific Chimeric Antigen Receptor | [CS] | 3 |
N0000175078 | CD20-directed Antibody Interactions | [MoA] | 15 |
N0000175657 | CD20-directed Cytolytic Antibody | [EPC] | 15 |
N0000193616 | CD22-directed Antibody Interactions | [MoA] | 1 |
N0000193617 | CD22-directed Immunoconjugate | [EPC] | 1 |
N0000175618 | CD3 Receptor Agonists | [MoA] | 1 |
N0000182966 | CD30-directed Antibody Interactions | [MoA] | 1 |
N0000182967 | CD30-directed Immunoconjugate | [EPC] | 1 |
N0000175077 | CD33-directed Antibody Interactions | [MoA] | 1 |
N0000175571 | CD33-directed Immunoconjugate | [EPC] | 1 |
N0000192335 | CD38-directed Antibody Interactions | [MoA] | 5 |
N0000192336 | CD38-directed Cytolytic Antibody | [EPC] | 5 |
N0000175617 | CD3-directed Antibody Interactions | [MoA] | 1 |
N0000193805 | CD4-directed Antibody Interactions | [MoA] | 1 |
N0000193806 | CD4-directed Blocking Antibody | [EPC] | 1 |
N0000175079 | CD52-directed Antibody Interactions | [MoA] | 2 |
N0000175659 | CD52-directed Cytolytic Antibody | [EPC] | 2 |
N0000182150 | CD80-directed Antibody Interactions | [MoA] | 1 |
N0000182151 | CD86-directed Antibody Interactions | [MoA] | 1 |
N0000184306 | Cell-mediated Immunity | [PE] | 5839 |
N0000185022 | Cells, Allogeneic | [EXT] | 1 |
N0000184310 | Cells, Cultured, Autologous | [EXT] | 2 |
N0000185377 | Cells, Epidermal | [EXT] | 110 |
N0000175554 | Central alpha-2 Adrenergic Agonist | [EPC] | 510 |
N0000175758 | Central Nervous System Depressant | [EPC] | 9 |
N0000175728 | Central Nervous System Depression | [PE] | 163 |
N0000175739 | Central Nervous System Stimulant | [EPC] | 1772 |
N0000175729 | Central Nervous System Stimulation | [PE] | 1506 |
N0000175730 | Centrally-mediated Muscle Relaxation | [PE] | 610 |
N0000175488 | Cephalosporin Antibacterial | [EPC] | 572 |
M0003827 | Cephalosporins | [CS] | 572 |
N0000000087 | Chelating Activity | [MoA] | 13 |
N0000175445 | Chemokine Co-receptor 5 Antagonists | [MoA] | 12 |
N0000193866 | Chemokine Receptor Type 4 Interaction | [EPC] | 1 |
N0000193867 | Chemokine Receptor Type 4 Interactions | [MoA] | 1 |
M0028909 | Chickenpox Vaccine | [CS] | 2 |
N0000184145 | Chloride Channel Activation Potentiators | [MoA] | 11 |
N0000175573 | Chloride Channel Activator | [EPC] | 31 |
N0000175456 | Chloride Channel Activators | [MoA] | 31 |
M0004229 | Cholecalciferol | [CS] | 62 |
M0004235 | Cholecystokinin | [CS] | 4 |
N0000175798 | Cholecystokinin Analog | [EPC] | 4 |
N0000175369 | Cholinergic Agonists | [MoA] | 94 |
N0000175370 | Cholinergic Antagonists | [MoA] | 624 |
N0000175840 | Cholinergic Muscarinic Agonist | [EPC] | 25 |
N0000000104 | Cholinergic Muscarinic Agonists | [MoA] | 72 |
N0000175700 | Cholinergic Muscarinic Antagonist | [EPC] | 426 |
N0000000125 | Cholinergic Muscarinic Antagonists | [MoA] | 426 |
N0000175706 | Cholinergic Nicotinic Agonist | [EPC] | 703 |
N0000175884 | Cholinergic Receptor Agonist | [EPC] | 106 |
N0000175723 | Cholinesterase Inhibitor | [EPC] | 314 |
N0000000177 | Cholinesterase Inhibitors | [MoA] | 314 |
N0000175742 | Cholinesterase Reactivator | [EPC] | 1 |
N0000000080 | Cholinesterase Reactivators | [MoA] | 1 |
M0029561 | Chondrocytes | [CS] | 1 |
N0000193991 | Classical Complement Pathway Inhibitor | [EPC] | 1 |
N0000193990 | Classical Complement Pathway Inhibitors | [MoA] | 1 |
M0004775 | Collagen | [CS] | 2 |
N0000006395 | Collagenases | [Chemical/Ingredient] | 2 |
N0000175843 | Collagen-specific Enzyme | [EPC] | 2 |
N0000175686 | Competitive Opioid Antagonists | [MoA] | 21 |
N0000193973 | Complement 5a Receptor Antagonist | [EPC] | 1 |
N0000193974 | Complement 5a Receptor Antagonists | [MoA] | 1 |
N0000175575 | Complement Inhibitor | [EPC] | 6 |
N0000175974 | Complement Inhibitors | [MoA] | 6 |
N0000175864 | Contrast Agent for Ultrasound Imaging | [EPC] | 6 |
M0005152 | Copper | [CS] | 219 |
N0000175530 | Copper Absorption Inhibitor | [EPC] | 1266 |
N0000020075 | Copper Chelating Activity | [MoA] | 2 |
N0000194014 | Copper Chelator | [EPC] | 2 |
N0000175831 | Copper-containing Intrauterine Device | [EPC] | 219 |
N0000175576 | Corticosteroid | [EPC] | 2624 |
N0000175450 | Corticosteroid Hormone Receptor Agonists | [MoA] | 2685 |
N0000193935 | Cortisol Synthesis Inhibitor | [EPC] | 3 |
N0000182634 | CTLA-4-directed Antibody Interactions | [MoA] | 2 |
N0000182635 | CTLA-4-directed Blocking Antibody | [EPC] | 2 |
N0000193919 | Cyclic Pyranopterin Monophosphate | [EPC] | 2 |
N0000193920 | Cyclic Pyranopterin Monophosphate | [EXT] | 2 |
N0000193921 | Cyclin-dependent Kinase 4 Inhibitors | [MoA] | 1 |
N0000193922 | Cyclin-dependent Kinase 6 Inhibitors | [MoA] | 1 |
N0000175939 | Cyclooxygenase Inhibitor | [EPC] | 179 |
N0000000160 | Cyclooxygenase Inhibitors | [MoA] | 4064 |
N0000184146 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator | [EPC] | 11 |
N0000187051 | Cystine Depleting Agent | [EPC] | 8 |
N0000175549 | Cystine Disulfide Reduction | [MoA] | 13 |
N0000193984 | Cytochrome P450 11A1 Inhibitors | [MoA] | 1 |
N0000193936 | Cytochrome P450 11B1 Inhibitors | [MoA] | 3 |
N0000182633 | Cytochrome P450 17A1 Inhibitor | [EPC] | 41 |
N0000182632 | Cytochrome P450 17A1 Inhibitors | [MoA] | 42 |
N0000191624 | Cytochrome P450 1A Inducers | [MoA] | 18 |
N0000193954 | Cytochrome P450 1A1 Inhibitors | [MoA] | 21 |
N0000191266 | Cytochrome P450 1A2 Inducers | [MoA] | 245 |
N0000182138 | Cytochrome P450 1A2 Inhibitors | [MoA] | 269 |
N0000193937 | Cytochrome P450 2A6 Inhibitors | [MoA] | 1 |
N0000187064 | Cytochrome P450 2B6 Inducers | [MoA] | 305 |
N0000182139 | Cytochrome P450 2B6 Inhibitors | [MoA] | 18 |
N0000185607 | Cytochrome P450 2C19 Inducers | [MoA] | 259 |
N0000182140 | Cytochrome P450 2C19 Inhibitors | [MoA] | 1179 |
N0000187063 | Cytochrome P450 2C8 Inducers | [MoA] | 98 |
N0000187062 | Cytochrome P450 2C8 Inhibitors | [MoA] | 469 |
N0000185507 | Cytochrome P450 2C9 Inducers | [MoA] | 330 |
N0000185504 | Cytochrome P450 2C9 Inhibitors | [MoA] | 513 |
N0000191267 | Cytochrome P450 2D6 Inducers | [MoA] | 85 |
N0000182135 | Cytochrome P450 2D6 Inhibitor | [EPC] | 10 |
N0000182137 | Cytochrome P450 2D6 Inhibitors | [MoA] | 650 |
N0000193955 | Cytochrome P450 2E1 Inducers | [MoA] | 19 |
N0000190118 | Cytochrome P450 3A Inducers | [MoA] | 190 |
N0000191001 | Cytochrome P450 3A Inhibitor | [EPC] | 28 |
N0000190114 | Cytochrome P450 3A Inhibitors | [MoA] | 783 |
N0000185506 | Cytochrome P450 3A4 Inducers | [MoA] | 637 |
N0000182141 | Cytochrome P450 3A4 Inhibitors | [MoA] | 1047 |
N0000190115 | Cytochrome P450 3A5 Inhibitors | [MoA] | 59 |
N0000191548 | Cytolytic Agent | [EPC] | 1 |
N0000193800 | Cytomegalovirus DNA Terminase Complex Inhibitor | [EPC] | 4 |
N0000175461 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | [EPC] | 41 |
N0000193976 | Cytomegalovirus pUL97 Kinase Inhibitor | [EPC] | 1 |
N0000193977 | Cytomegalovirus pUL97 Kinase Inhibitors | [MoA] | 1 |
N0000180854 | Cytoprotective Agent | [EPC] | 33 |
N0000193862 | Cytotoxin | [EPC] | 1 |
M0005633 | Cytotoxins | [CS] | 1 |
M0576325 | Dander | [CS] | 36 |
N0000175845 | Decarboxylase Inhibitor | [EPC] | 1 |
N0000175844 | Decarboxylase Inhibitors | [MoA] | 1 |
N0000192801 | Decorporation Agent | [EPC] | 2 |
N0000175644 | Decreased Autonomic Ganglionic Activity | [PE] | 2 |
N0000182156 | Decreased B Lymphocyte Activation | [PE] | 3 |
N0000178477 | Decreased Blood Pressure | [PE] | 345 |
N0000008476 | Decreased Cell Membrane Integrity | [PE] | 1 |
N0000008478 | Decreased Cell Wall Integrity | [PE] | 179 |
N0000008479 | Decreased Cell Wall Synthesis & Repair | [PE] | 381 |
N0000008486 | Decreased Central Nervous System Disorganized Electrical Activity | [PE] | 2156 |
N0000008501 | Decreased Central Nervous System Organized Electrical Activity | [PE] | 8 |
N0000008553 | Decreased Cholesterol Absorption | [PE] | 93 |
N0000008556 | Decreased Coagulation Factor Activity | [PE] | 284 |
N0000175529 | Decreased Copper Ion Absorption | [PE] | 1255 |
N0000008571 | Decreased Cytokine Activity | [PE] | 4 |
N0000175360 | Decreased Diuresis | [PE] | 9 |
N0000008576 | Decreased DNA Integrity | [PE] | 1 |
N0000008577 | Decreased DNA Replication | [PE] | 34 |
N0000008595 | Decreased Embryonic Implantation | [PE] | 219 |
N0000175632 | Decreased Fibrinolysis | [PE] | 88 |
N0000008635 | Decreased GI Motility | [PE] | 20 |
N0000008636 | Decreased GI Smooth Muscle Tone | [PE] | 20 |
N0000008652 | Decreased Glycolysis | [PE] | 20 |
N0000008638 | Decreased GnRH Secretion | [PE] | 11 |
N0000175628 | Decreased Histamine Release | [PE] | 114 |
N0000175793 | Decreased IgE Activity | [PE] | 4 |
N0000175550 | Decreased Immunologic Activity | [PE] | 97 |
N0000008663 | Decreased Immunologically Active Molecule Activity | [PE] | 4 |
N0000008683 | Decreased Leukotriene Production | [PE] | 6 |
N0000008732 | Decreased Mitosis | [PE] | 26 |
N0000008779 | Decreased Parasympathetic Acetylcholine Activity | [PE] | 19 |
N0000008832 | Decreased Platelet Aggregation | [PE] | 983 |
N0000175972 | Decreased Platelet Production | [PE] | 5 |
N0000008836 | Decreased Prostaglandin Production | [PE] | 1238 |
N0000008841 | Decreased Protein Synthesis | [PE] | 45 |
N0000193995 | Decreased Prothrombin Activity | [PE] | 57 |
N0000008859 | Decreased Renal K+ Excretion | [PE] | 85 |
N0000008867 | Decreased Respiratory Secretion Viscosity | [PE] | 1247 |
N0000008852 | Decreased RNA Integrity | [PE] | 3 |
N0000008853 | Decreased RNA Replication | [PE] | 34 |
N0000009982 | Decreased Sebaceous Gland Activity | [PE] | 383 |
N0000008924 | Decreased Sperm Motility | [PE] | 219 |
N0000008953 | Decreased Striated Muscle Contraction | [PE] | 29 |
N0000175735 | Decreased Striated Muscle Tone | [PE] | 29 |
N0000009010 | Decreased Tracheobronchial Stretch Receptor Activity | [PE] | 159 |
N0000010252 | Decreased Vascular Permeability | [PE] | 1 |
N0000175535 | Demulcent | [EPC] | 1 |
N0000175532 | Demulcent Activity | [MoA] | 1 |
M0006007 | Deoxyribonuclease I | [CS] | 1 |
M0006020 | Deoxyuridine | [CS] | 3 |
N0000175851 | Depigmenting Activity | [PE] | 33 |
N0000175719 | Depolarizing Neuromuscular Blocker | [EPC] | 46 |
N0000175536 | Diagnostic Dye | [EPC] | 19 |
N0000186775 | Diarylquinoline Antimycobacterial | [EPC] | 2 |
M0582947 | Diarylquinolines | [CS] | 2 |
N0000175911 | Dietary Cholesterol Absorption Inhibitor | [EPC] | 93 |
M0006342 | Dietary Proteins | [CS] | 1740 |
N0000009022 | Digestive/GI System Activity Alteration | [PE] | 19 |
N0000175489 | Dihydrofolate Reductase Inhibitor Antibacterial | [EPC] | 135 |
N0000175934 | Dihydrofolate Reductase Inhibitor Antimalarial | [EPC] | 6 |
N0000000191 | Dihydrofolate Reductase Inhibitors | [MoA] | 367 |
N0000185501 | Dihydroorotate Dehydrogenase Inhibitors | [MoA] | 46 |
N0000175421 | Dihydropyridine Calcium Channel Blocker | [EPC] | 753 |
M0006414 | Dihydropyridines | [CS] | 753 |
N0000175513 | Dipeptidase Inhibitors | [MoA] | 9 |
N0000175913 | Dipeptidyl Peptidase 4 Inhibitor | [EPC] | 88 |
N0000175912 | Dipeptidyl Peptidase 4 Inhibitors | [MoA] | 88 |
M0006519 | Diphosphonates | [CS] | 129 |
M0006523 | Diphtheria Toxoid | [CS] | 16 |
N0000175518 | Direct Thrombin Inhibitor | [EPC] | 54 |
N0000194020 | Disclosing Agent | [EPC] | 1 |
M0006609 | Diterpenes | [CS] | 1 |
N0000020060 | DNA Polymerase Inhibitors | [MoA] | 403 |
N0000193801 | DNA Terminase Complex Inhibitors | [MoA] | 4 |
N0000000117 | Dopamine Agonists | [MoA] | 312 |
N0000175799 | Dopamine D2 Antagonists | [MoA] | 53 |
N0000000114 | Dopamine Uptake Inhibitors | [MoA] | 331 |
N0000175800 | Dopamine-2 Receptor Antagonist | [EPC] | 53 |
N0000175580 | Dopaminergic Agonist | [EPC] | 9 |
N0000175533 | Dyes | [MoA] | 20 |
N0000175507 | Echinocandin Antifungal | [EPC] | 48 |
M0023708 | Egg Proteins, Dietary | [CS] | 21 |
N0000009034 | Emesis Suppression | [PE] | 199 |
N0000184012 | Endogenous Antigen Neutralization | [MoA] | 13 |
N0000175531 | Endoglycosidase | [EPC] | 23 |
N0000175581 | Endothelin Receptor Antagonist | [EPC] | 38 |
N0000175364 | Endothelin Receptor Antagonists | [MoA] | 38 |
N0000175664 | Epidermal Growth Factor Receptor Antagonist | [EPC] | 5 |
N0000192345 | Epoxide Hydrolase Inhibitors | [MoA] | 7 |
M0007651 | Ergocalciferols | [CS] | 109 |
M0007652 | Ergolines | [CS] | 30 |
N0000175827 | Ergot Derivative | [EPC] | 30 |
N0000175766 | Ergotamine Derivative | [EPC] | 20 |
M0007665 | Ergotamines | [CS] | 20 |
N0000194025 | Erythroid Maturation Agent | [EPC] | 2 |
N0000175665 | Erythropoiesis-stimulating Agent | [EPC] | 50 |
M0007726 | Erythropoietin | [CS] | 50 |
N0000175683 | Ester Local Anesthetic | [EPC] | 48 |
M0007766 | Esters | [CS] | 48 |
M0007772 | Estradiol | [CS] | 1 |
M0447348 | Estradiol Congeners | [CS] | 282 |
N0000175825 | Estrogen | [EPC] | 342 |
N0000175826 | Estrogen Agonist/Antagonist | [EPC] | 60 |
N0000000100 | Estrogen Receptor Agonists | [MoA] | 342 |
N0000175582 | Estrogen Receptor Antagonist | [EPC] | 24 |
N0000000145 | Estrogen Receptor Antagonists | [MoA] | 24 |
M0007792 | Estrogens, Conjugated (USP) | [CS] | 18 |
N0000193956 | Expectorant | [EPC] | 1211 |
M0008146 | Factor VIII | [CS] | 1 |
N0000175916 | Factor VIII Activator | [EPC] | 57 |
N0000175637 | Factor Xa Inhibitor | [EPC] | 57 |
N0000175635 | Factor Xa Inhibitors | [MoA] | 57 |
N0000192561 | Farnesoid X Receptor Agonist | [EPC] | 2 |
N0000192560 | Farnesoid X Receptor Agonists | [MoA] | 2 |
N0000193938 | Farnesyltransferase Inhibitor | [EPC] | 2 |
N0000193939 | Farnesyltransferase Inhibitors | [MoA] | 2 |
M0023885 | Fatty Acids, Omega-3 | [CS] | 32 |
M0008280 | Feathers | [CS] | 44 |
M0168688 | Fibroblast Growth Factor 7 | [CS] | 1 |
N0000194026 | Fibroblast Growth Factor Receptor Inhibitors | [MoA] | 3 |
N0000185014 | Fish Proteins, Dietary | [EXT] | 24 |
N0000193981 | Fluorescence Contrast Activity | [MoA] | 3 |
N0000193223 | Fluoroquinolone Antibacterial | [EPC] | 98 |
M0372253 | Fluoroquinolones | [CS] | 98 |
N0000178369 | Folate Analog | [EPC] | 73 |
N0000175584 | Folate Analog Metabolic Inhibitor | [EPC] | 148 |
M0008658 | Folic Acid | [CS] | 73 |
N0000000111 | Folic Acid Metabolism Inhibitors | [MoA] | 143 |
M0008672 | Food Additives | [CS] | 394 |
N0000000170 | Free Radical Scavenging Activity | [MoA] | 1 |
N0000185015 | Fruit Proteins | [EXT] | 90 |
N0000175684 | Full Opioid Agonists | [MoA] | 1157 |
M0008890 | Fungal Proteins | [CS] | 589 |
N0000169106 | Fungal Proteins | [Chemical/Ingredient] | 12 |
N0000175615 | Fusion Protein Inhibitors | [MoA] | 4 |
N0000000196 | GABA A Agonists | [MoA] | 353 |
N0000193997 | GABA A Receptor Positive Modulators | [MoA] | 8 |
N0000000116 | GABA B Agonists | [MoA] | 198 |
N0000183362 | Gadolinium-based Contrast Agent | [EPC] | 23 |
N0000183360 | gamma-Aminobutyric Acid A Receptor Agonist | [EPC] | 18 |
N0000175759 | gamma-Aminobutyric Acid-ergic Agonist | [EPC] | 335 |
M0081434 | gamma-Cyclodextrins | [CS] | 5 |
N0000190853 | Gastrointestinal Motility Inhibitor | [EPC] | 20 |
N0000175975 | General Anesthesia | [PE] | 188 |
N0000175681 | General Anesthetic | [EPC] | 110 |
N0000193549 | Genetically-modified Autologous T Cells | [EPC] | 3 |
N0000009059 | Genitourinary Arterial Vasodilation | [PE] | 14 |
N0000009048 | GI Motility Alteration | [PE] | 19 |
N0000175428 | Glinide | [EPC] | 49 |
N0000178480 | GLP-1 Receptor Agonist | [EPC] | 53 |
N0000190992 | GLP-2 Analog | [EPC] | 1 |
N0000193923 | Glucagon Receptor Agonists | [MoA] | 4 |
M0160181 | Glucagon-Like Peptide 1 | [CS] | 35 |
N0000175140 | Glucagon-Like Peptide 2 | [Chemical/Ingredient] | 1 |
N0000020058 | Glucagon-like Peptide-1 (GLP-1) Agonists | [MoA] | 53 |
N0000190990 | Glucagon-like Peptide-2 (GLP-2) Agonists | [MoA] | 1 |
N0000020027 | Glucan Synthase Inhibitors | [MoA] | 1 |
N0000194015 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist | [EPC] | 18 |
M0009360 | Glucosylceramidase | [CS] | 2 |
N0000175783 | Glucosylceramide Synthase Inhibitor | [EPC] | 6 |
N0000020019 | Glucosylceramide Synthase Inhibitors | [MoA] | 6 |
M0009417 | Glycerol | [CS] | 282 |
N0000191500 | Glycolipid Disialoganglioside-directed Antibody | [EPC] | 2 |
N0000191499 | Glycolipid Disialoganglioside-directed Antibody Interactions | [MoA] | 2 |
N0000175491 | Glycopeptide Antibacterial | [EPC] | 131 |
M0009481 | Glycopeptides | [CS] | 131 |
N0000193994 | Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions | [MoA] | 1 |
N0000175837 | Glycosaminoglycan | [EPC] | 1 |
M0009496 | Glycosaminoglycans | [CS] | 1 |
M0009499 | Glycoside Hydrolases | [CS] | 23 |
N0000175838 | Gonadotropin | [EPC] | 16 |
N0000175655 | Gonadotropin Releasing Hormone Receptor Agonist | [EPC] | 8 |
N0000175654 | Gonadotropin Releasing Hormone Receptor Agonists | [MoA] | 8 |
N0000175839 | Gonadotropin Releasing Hormone Receptor Antagonist | [EPC] | 11 |
N0000175084 | Gonadotropin Releasing Hormone Receptor Antagonists | [MoA] | 11 |
M0009540 | Gonadotropins | [CS] | 16 |
N0000000152 | G-Protein-linked Receptor Interactions | [MoA] | 18 |
N0000185016 | Grain Proteins | [EXT] | 254 |
M0024696 | Granulocyte Colony-Stimulating Factor | [CS] | 28 |
M0024695 | Granulocyte-Macrophage Colony-Stimulating Factor | [CS] | 28 |
N0000193785 | Growth Hormone Secretagogue Receptor Agonist | [EPC] | 2 |
N0000193786 | Growth Hormone Secretagogue Receptor Agonists | [MoA] | 2 |
N0000185499 | Guanylate Cyclase Activators | [MoA] | 5 |
N0000190484 | Guanylate Cyclase Stimulators | [MoA] | 8 |
N0000185500 | Guanylate Cyclase-C Agonist | [EPC] | 5 |
M0027264 | Haemophilus Vaccines | [CS] | 2 |
N0000182638 | HCV NS3/4A Protease Inhibitors | [MoA] | 4 |
N0000184149 | Hedgehog Pathway Inhibitor | [EPC] | 4 |
N0000175886 | Helicobacter pylori Diagnostic | [EPC] | 1 |
N0000009065 | Hematologic Activity Alteration | [PE] | 7 |
N0000178326 | Hematopoietic Stem Cell Mobilizer | [EPC] | 10 |
M0010055 | Hematopoietic Stem Cells | [CS] | 1 |
N0000194027 | Hemoglobin S Polymerization Inhibitor | [EPC] | 3 |
N0000194028 | Hemoglobin S Polymerization Inhibitors | [MoA] | 3 |
M0010187 | Heparin | [CS] | 127 |
N0000175981 | Heparin Binding Activity | [MoA] | 4 |
N0000175983 | Heparin Reversal Agent | [EPC] | 4 |
M0010191 | Heparin, Low-Molecular-Weight | [CS] | 168 |
M0357587 | Hepatitis A Vaccines | [CS] | 14 |
M0026310 | Hepatitis B Vaccines | [CS] | 9 |
N0000175656 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [EPC] | 204 |
N0000182639 | Hepatitis C Virus NS3/4A Protease Inhibitor | [EPC] | 4 |
N0000191256 | Hepatitis C Virus NS5A Inhibitor | [EPC] | 14 |
N0000191493 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor | [EPC] | 15 |
N0000020010 | HER1 Antagonists | [MoA] | 6 |
N0000175661 | HER2/neu Receptor Antagonist | [EPC] | 12 |
N0000020008 | HER2/Neu/cerbB2 Antagonists | [MoA] | 12 |
N0000180187 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | [EPC] | 322 |
M0491099 | Herpes Zoster Vaccine | [CS] | 2 |
N0000180188 | Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor | [EPC] | 322 |
N0000175468 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor | [EPC] | 354 |
N0000000190 | Histamine H1 Receptor Antagonists | [MoA] | 2518 |
N0000000151 | Histamine H2 Receptor Antagonists | [MoA] | 467 |
N0000000207 | Histamine Receptor Antagonists | [MoA] | 771 |
N0000175587 | Histamine-1 Receptor Antagonist | [EPC] | 2459 |
N0000175519 | Histamine-1 Receptor Inhibitor | [EPC] | 127 |
N0000175784 | Histamine-2 Receptor Antagonist | [EPC] | 467 |
N0000175588 | Histone Deacetylase Inhibitor | [EPC] | 3 |
N0000175071 | Histone Deacetylase Inhibitors | [MoA] | 3 |
N0000193807 | HIV 1 Post-attachment Fusion Inhibitors | [MoA] | 1 |
N0000000127 | HIV Integrase Inhibitors | [MoA] | 25 |
N0000000246 | HIV Protease Inhibitors | [MoA] | 77 |
N0000175589 | HMG-CoA Reductase Inhibitor | [EPC] | 1214 |
M0006896 | House Dust | [CS] | 20 |
N0000184171 | Human alpha-1 Proteinase Inhibitor | [EPC] | 2 |
N0000184167 | Human Antihemophilic Factor | [EPC] | 1 |
N0000184169 | Human Blood Coagulation Factor | [EPC] | 18 |
N0000184172 | Human C1 Esterase Inhibitor | [EPC] | 1 |
M0028842 | Human Growth Hormone | [CS] | 51 |
N0000175463 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor | [EPC] | 59 |
N0000193808 | Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor | [EPC] | 1 |
N0000175887 | Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor | [EPC] | 25 |
N0000175462 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | [EPC] | 195 |
N0000184164 | Human Immunoglobulin | [EPC] | 7 |
N0000184165 | Human Immunoglobulin G | [EPC] | 69 |
N0000175885 | Human Platelet-derived Growth Factor | [EPC] | 1 |
N0000184174 | Human Serum Albumin | [EPC] | 29 |
N0000191873 | Humanized Monoclonal Antibody Fragment | [EPC] | 1 |
N0000192342 | Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme | [EPC] | 1 |
N0000175820 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme | [EPC] | 3 |
N0000175821 | Hydrolytic Lysosomal Glycogen-specific Enzyme | [EPC] | 2 |
N0000175823 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme | [EPC] | 4 |
N0000175822 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme | [EPC] | 2 |
N0000192343 | Hydrolytic Lysosomal Triacylglycerol-specific Enzyme | [EPC] | 1 |
N0000000121 | Hydroxymethylglutaryl-CoA Reductase Inhibitors | [MoA] | 1214 |
N0000175808 | Hydroxyphenylpyruvate Dioxygenase Inhibitors | [MoA] | 22 |
N0000191546 | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists | [MoA] | 4 |
N0000191544 | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker | [EPC] | 4 |
N0000193998 | Hypoxia-inducible Factor 2 alpha Inhibitors | [MoA] | 1 |
N0000193999 | Hypoxia-inducible Factor Inhibitor | [EPC] | 1 |
N0000175792 | IgE-directed Antibody Interactions | [MoA] | 4 |
N0000193957 | Ileal Bile Acid Transporter Inhibitor | [EPC] | 5 |
N0000193958 | Ileal Bile Acid Transporter Inhibitors | [MoA] | 5 |
M0461078 | Imidazolines | [CS] | 197 |
M0028142 | Immunoconjugates | [CS] | 2 |
N0000184163 | Immunoglobulin G | [EPC] | 5 |
M0011122 | Immunoglobulins | [CS] | 80 |
N0000183896 | Inactivated Bordetella Pertussis Vaccine | [EPC] | 11 |
N0000183900 | Inactivated Clostridium Tetani Vaccine | [EPC] | 21 |
N0000183887 | Inactivated Corynebacterium Diphtheriae Vaccine | [EPC] | 16 |
N0000183888 | Inactivated Haemophilus Influenzae B Vaccine | [EPC] | 2 |
N0000183889 | Inactivated Hepatitis A Virus Vaccine | [EPC] | 14 |
N0000183890 | Inactivated Hepatitis B Virus Vaccine | [EPC] | 9 |
N0000183891 | Inactivated Human Papillomavirus Vaccine | [EPC] | 5 |
N0000183892 | Inactivated Influenza A Virus Vaccine | [EPC] | 1 |
N0000183894 | Inactivated Japanese Encephalitis Virus Vaccine | [EPC] | 4 |
N0000183895 | Inactivated Meningococcal Vaccine | [EPC] | 3 |
N0000183897 | Inactivated Pneumococcal Vaccine | [EPC] | 6 |
N0000183898 | Inactivated Poliovirus Vaccine | [EPC] | 11 |
N0000183910 | Inactivated Salmonella Typhi Vaccine | [EPC] | 3 |
N0000178478 | Increased Blood Pressure | [PE] | 57 |
N0000020081 | Increased Calcium-sensing Receptor Sensitivity | [MoA] | 61 |
N0000009176 | Increased Cellular Death | [PE] | 4 |
N0000175979 | Increased Coagulation Activity | [PE] | 17 |
N0000009252 | Increased Coagulation Factor Activity | [PE] | 937 |
N0000175914 | Increased Coagulation Factor VIII Activity | [PE] | 57 |
N0000175915 | Increased Coagulation Factor VIII Concentration | [PE] | 57 |
N0000009267 | Increased Cytokine Activity | [PE] | 13 |
N0000009269 | Increased Cytokine Production | [PE] | 13 |
N0000175359 | Increased Diuresis | [PE] | 1110 |
N0000175366 | Increased Diuresis at Loop of Henle | [PE] | 323 |
N0000009282 | Increased Dopamine Activity | [PE] | 331 |
N0000175675 | Increased Epithelial Proliferation | [PE] | 1 |
N0000009319 | Increased Erythroid Cell Production | [PE] | 52 |
N0000009340 | Increased Gluconeogenesis | [PE] | 20 |
N0000175960 | Increased Glutathione Concentration | [PE] | 35 |
N0000009345 | Increased Glycogenolysis | [PE] | 24 |
N0000178324 | Increased Hematopoietic Stem Cell Mobilization | [PE] | 10 |
N0000175629 | Increased Histamine Release | [PE] | 5817 |
N0000185001 | Increased IgG Production | [PE] | 3508 |
N0000009357 | Increased Immunologically Active Molecule Activity | [PE] | 2 |
N0000009361 | Increased Intravascular Volume | [PE] | 75 |
N0000009371 | Increased Large Intestinal Motility | [PE] | 2478 |
N0000178328 | Increased Lymphocyte Activation | [PE] | 7 |
N0000009391 | Increased Lymphocyte Cell Production | [PE] | 7 |
N0000183884 | Increased Macrophage Proliferation | [PE] | 2 |
N0000009393 | Increased Medullary Respiratory Drive | [PE] | 2 |
N0000175969 | Increased Megakaryocyte Maturation | [PE] | 9 |
N0000009451 | Increased Myeloid Cell Production | [PE] | 28 |
N0000009456 | Increased Norepinephrine Activity | [PE] | 363 |
N0000009457 | Increased Oncotic Pressure | [PE] | 29 |
N0000009524 | Increased Platelet Aggregation | [PE] | 1 |
N0000175970 | Increased Platelet Production | [PE] | 9 |
N0000009526 | Increased Prostaglandin Activity | [PE] | 6 |
N0000009531 | Increased Protein Breakdown | [PE] | 3 |
N0000009533 | Increased Protein Synthesis | [PE] | 3 |
N0000175965 | Increased Prothrombin Activity | [PE] | 33 |
N0000009560 | Increased Respiratory Secretions | [PE] | 1211 |
N0000175651 | Increased Sympathetic Activity | [PE] | 449 |
N0000182157 | Increased T Lymphocyte Activation | [PE] | 5 |
N0000009689 | Increased T Lymphocyte Destruction | [PE] | 5 |
N0000009705 | Increased Uterine Smooth Muscle Contraction or Tone | [PE] | 23 |
N0000175543 | Influenza A M2 Protein Inhibitor | [EPC] | 49 |
M0011310 | Influenza Vaccines | [CS] | 1 |
N0000175866 | Inhalation Diagnostic Agent | [EPC] | 4 |
N0000175830 | Inhibit Ovum Fertilization | [PE] | 282 |
N0000009724 | Inhibition Gastric Acid Secretion | [PE] | 162 |
N0000009726 | Inhibition Large Intestine Fluid/Electrolyte Absorption | [PE] | 2242 |
N0000009730 | Inhibition Small Intestine Fluid/Electrolyte Absorption | [PE] | 1096 |
M0028968 | Insect Proteins | [CS] | 124 |
N0000007860 | Insect Proteins | [Chemical/Ingredient] | 18 |
N0000004931 | Insulin | [Chemical/Ingredient] | 38 |
M0011417 | Insulin | [CS] | 98 |
N0000175944 | Insulin | [EPC] | 28 |
N0000175453 | Insulin Analog | [EPC] | 108 |
N0000193926 | Insulin-like Growth Factor-1 Receptor Inhibitor | [EPC] | 1 |
N0000193927 | Insulin-like Growth Factor-1 Receptor Inhibitors | [MoA] | 1 |
N0000175775 | Integrin Receptor Antagonist | [EPC] | 4 |
N0000175774 | Integrin Receptor Antagonists | [MoA] | 4 |
N0000193982 | Interferon alfa-2b | [EPC] | 1 |
M0023695 | Interferon alfa-2b | [CS] | 1 |
N0000175521 | Interferon alpha | [EPC] | 6 |
N0000191625 | Interferon beta | [EPC] | 9 |
N0000175541 | Interferon gamma | [EPC] | 10 |
N0000193855 | Interferon gamma Antagonists | [MoA] | 7 |
N0000193856 | Interferon gamma Blocker | [EPC] | 7 |
N0000000157 | Interferon Inducers | [MoA] | 13 |
M0025711 | Interferon-alpha | [CS] | 6 |
M0025715 | Interferon-beta | [CS] | 9 |
M0011490 | Interferon-gamma | [CS] | 10 |
N0000175709 | Interleukin 1 Receptor Antagonists | [MoA] | 1 |
N0000193279 | Interleukin 17 Receptor A Antagonists | [MoA] | 1 |
N0000010279 | Interleukin 2 Receptor Antagonists | [MoA] | 2 |
N0000175621 | Interleukin 2 Receptor-directed Antibody Interactions | [MoA] | 2 |
N0000193341 | Interleukin 4 Receptor alpha Antagonists | [MoA] | 5 |
N0000193802 | Interleukin 5 Receptor alpha-directed Antibody Interactions | [MoA] | 2 |
N0000190478 | Interleukin 6 Receptor Antagonists | [MoA] | 9 |
N0000175710 | Interleukin-1 Receptor Antagonist | [EPC] | 1 |
N0000192797 | Interleukin-12 Antagonist | [EPC] | 3 |
N0000192796 | Interleukin-12 Antagonists | [MoA] | 3 |
N0000193985 | Interleukin-13 Antagonist | [EPC] | 1 |
N0000193986 | Interleukin-13 Antagonists | [MoA] | 1 |
N0000193276 | Interleukin-17 Receptor A Antagonist | [EPC] | 1 |
N0000191495 | Interleukin-17A Antagonist | [EPC] | 6 |
N0000191494 | Interleukin-17A Antagonists | [MoA] | 6 |
M0011506 | Interleukin-2 | [CS] | 7 |
N0000175622 | Interleukin-2 Receptor Blocking Antibody | [EPC] | 2 |
N0000192799 | Interleukin-23 Antagonist | [EPC] | 10 |
N0000192798 | Interleukin-23 Antagonists | [MoA] | 10 |
N0000193342 | Interleukin-4 Receptor alpha Antagonist | [EPC] | 5 |
N0000191872 | Interleukin-5 Antagonist | [EPC] | 4 |
N0000191871 | Interleukin-5 Antagonists | [MoA] | 4 |
N0000193803 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody | [EPC] | 2 |
N0000191006 | Interleukin-6 Antagonist | [EPC] | 2 |
N0000191004 | Interleukin-6 Antagonists | [MoA] | 2 |
N0000190480 | Interleukin-6 Receptor Antagonist | [EPC] | 9 |
N0000175591 | Intestinal Lipase Inhibitor | [EPC] | 3 |
N0000175356 | Ion Exchange Activity | [MoA] | 2 |
M0011718 | Iron | [CS] | 65 |
N0000000144 | Iron Chelating Activity | [MoA] | 127 |
N0000175522 | Iron Chelator | [EPC] | 127 |
N0000175534 | Irrigation | [MoA] | 2 |
N0000193987 | Isocitrate Dehydrogenase 1 Inhibitor | [EPC] | 1 |
N0000193988 | Isocitrate Dehydrogenase 1 Inhibitors | [MoA] | 1 |
N0000193615 | Isocitrate Dehydrogenase 2 Inhibitor | [EPC] | 2 |
N0000193614 | Isocitrate Dehydrogenase 2 Inhibitors | [MoA] | 2 |
N0000190858 | Janus Kinase Inhibitor | [EPC] | 25 |
N0000190857 | Janus Kinase Inhibitors | [MoA] | 25 |
M0357284 | Japanese Encephalitis Vaccines | [CS] | 4 |
N0000184151 | Kallikrein Inhibitors | [MoA] | 5 |
N0000175605 | Kinase Inhibitor | [EPC] | 374 |
N0000175082 | Kinase Inhibitors | [MoA] | 33 |
N0000175962 | Lead Chelating Activity | [MoA] | 11 |
N0000175963 | Lead Chelator | [EPC] | 11 |
N0000170333 | Leptin | [Chemical/Ingredient] | 1 |
N0000190854 | Leptin Analog | [EPC] | 1 |
N0000175666 | Leukocyte Growth Factor | [EPC] | 28 |
M0012412 | Leukocytes, Mononuclear | [CS] | 1 |
N0000175777 | Leukotriene Receptor Antagonist | [EPC] | 137 |
N0000000083 | Leukotriene Receptor Antagonists | [MoA] | 137 |
N0000175443 | Lincosamide Antibacterial | [EPC] | 256 |
M0515779 | Lincosamides | [CS] | 256 |
N0000009916 | Lipase Inhibitors | [MoA] | 3 |
N0000191261 | Lipid Emulsion | [EPC] | 30 |
N0000175510 | Lipid-based Polyene Antifungal | [EPC] | 5 |
M0012553 | Lipids | [CS] | 28 |
N0000191281 | Lipoglycopeptide Antibacterial | [EPC] | 4 |
N0000191280 | Lipoglycopeptides | [EXT] | 2 |
M000640741 | Lipoglycopeptides | [CS] | 2 |
N0000175509 | Lipopeptide Antibacterial | [EPC] | 54 |
M0519359 | Lipopeptides | [CS] | 102 |
N0000183903 | Live Attenuated Bacillus Anthracis Vaccine | [EPC] | 2 |
N0000183904 | Live Attenuated Bacillus Calmette-Guerin Vaccine | [EPC] | 2 |
N0000183905 | Live Attenuated Herpes Zoster Virus Vaccine | [EPC] | 2 |
N0000183907 | Live Attenuated Measles Virus Vaccine | [EPC] | 3 |
N0000183908 | Live Attenuated Rotavirus Vaccine | [EPC] | 1 |
N0000183909 | Live Attenuated Rubella Virus Vaccine | [EPC] | 3 |
N0000183911 | Live Attenuated Varicella Zoster Virus Vaccine | [EPC] | 2 |
N0000183912 | Live Attenuated Yellow Fever Virus Vaccine | [EPC] | 2 |
N0000183913 | Live Human Adenovirus Type 4 Vaccine | [EPC] | 20 |
N0000183914 | Live Human Adenovirus Type 7 Vaccine | [EPC] | 11 |
N0000183916 | Live Rotavirus Vaccine | [EPC] | 1 |
N0000183917 | Live Vaccinia Virus Vaccine | [EPC] | 14 |
N0000175976 | Local Anesthesia | [PE] | 1595 |
N0000175539 | Local Anesthetic | [EPC] | 10 |
N0000175590 | Loop Diuretic | [EPC] | 323 |
N0000175586 | Low Molecular Weight Heparin | [EPC] | 168 |
N0000175945 | l-Thyroxine | [EPC] | 557 |
N0000175946 | l-Triiodothyronine | [EPC] | 81 |
N0000178327 | Lymphocyte Function Alteration | [PE] | 5 |
N0000192701 | Lymphocyte Function-Associated Antigen-1 Antagonist | [EPC] | 2 |
N0000192700 | Lymphocyte Function-Associated Antigen-1 Antagonists | [MoA] | 2 |
N0000175667 | Lymphocyte Growth Factor | [EPC] | 7 |
N0000193804 | Lysosomal beta Glucuronidase | [EPC] | 1 |
N0000175542 | M2 Protein Inhibitors | [MoA] | 49 |
N0000175877 | Macrolide | [EPC] | 116 |
N0000175431 | Macrolide Antibacterial | [EPC] | 2 |
N0000175935 | Macrolide Antimicrobial | [EPC] | 409 |
M0028311 | Macrolides | [CS] | 411 |
N0000175834 | Magnesium Ion Exchange Activity | [MoA] | 1096 |
N0000175862 | Magnetic Resonance Contrast Activity | [MoA] | 184 |
N0000175630 | Mast Cell Stabilizer | [EPC] | 87 |
M0013153 | Measles Vaccine | [CS] | 3 |
N0000185017 | Meat Proteins | [EXT] | 114 |
N0000194023 | Medium-chain Triglyceride | [EPC] | 1 |
N0000175854 | Melanin Synthesis Inhibitor | [EPC] | 33 |
N0000175850 | Melanin Synthesis Inhibitors | [MoA] | 33 |
N0000193940 | Melanocortin 4 Receptor Agonist | [EPC] | 1 |
N0000193941 | Melanocortin 4 Receptor Agonists | [MoA] | 1 |
N0000175743 | Melatonin Receptor Agonist | [EPC] | 33 |
N0000000250 | Melatonin Receptor Agonists | [MoA] | 33 |
M0357647 | Meningococcal Vaccines | [CS] | 3 |
N0000193929 | Mesenchymal Epithelial Transition Inhibitors | [MoA] | 3 |
N0000175472 | Metal Chelating Activity | [MoA] | 18 |
N0000175473 | Metal Chelator | [EPC] | 16 |
N0000175511 | Methylated Sulfonamide Antibacterial | [EPC] | 3 |
N0000175512 | Methylated Sulfonamides | [EXT] | 3 |
N0000175804 | Methylating Activity | [MoA] | 15 |
N0000175805 | Methylating Agent | [EPC] | 15 |
N0000193930 | Methyltransferase Inhibitor | [EPC] | 1 |
N0000193931 | Methyltransferase Inhibitors | [MoA] | 1 |
N0000175790 | Methylxanthine | [EPC] | 578 |
N0000186779 | Microsomal Triglyceride Transfer Protein Inhibitor | [EPC] | 7 |
N0000186778 | Microsomal Triglyceride Transfer Protein Inhibitors | [MoA] | 7 |
N0000175085 | Microtubule Inhibition | [PE] | 125 |
N0000175592 | Microtubule Inhibitor | [EPC] | 102 |
M0013890 | Milk Proteins | [CS] | 38 |
N0000000139 | Mineralocorticoid Receptor Antagonists | [MoA] | 2 |
N0000193943 | Mitogen-Activated Protein Kinase Kinase 1 Inhibitors | [MoA] | 2 |
N0000193944 | Mitogen-Activated Protein Kinase Kinase 2 Inhibitors | [MoA] | 2 |
N0000175744 | Monoamine Oxidase Inhibitor | [EPC] | 40 |
N0000000184 | Monoamine Oxidase Inhibitors | [MoA] | 40 |
N0000175762 | Monoamine Oxidase Type B Inhibitor | [EPC] | 15 |
N0000175761 | Monoamine Oxidase-B Inhibitors | [MoA] | 15 |
N0000175493 | Monobactam Antibacterial | [EPC] | 10 |
M0014030 | Monobactams | [CS] | 10 |
N0000193863 | Monoclonal Antibody | [EPC] | 1 |
N0000175751 | Mood Stabilizer | [EPC] | 850 |
N0000175625 | mTOR Inhibitor Immunosuppressant | [EPC] | 97 |
N0000175624 | mTOR Inhibitors | [MoA] | 97 |
N0000175671 | Mucocutaneous Epithelial Cell Growth Factor | [EPC] | 1 |
N0000175776 | Mucolytic | [EPC] | 35 |
N0000191423 | Multidrug and Toxin Extrusion Transporter 1 Inhibitors | [MoA] | 33 |
N0000193932 | Multidrug and Toxin Extrusion Transporter 2 K Inhibitors | [MoA] | 11 |
M0014203 | Mumps Vaccine | [CS] | 3 |
N0000191867 | mu-Opioid Receptor Agonist | [EPC] | 2 |
N0000175737 | Muscle Relaxant | [EPC] | 565 |
N0000020069 | N-Calcium Channel Receptor Antagonists | [MoA] | 3 |
N0000194004 | Neonatal Fc Receptor Blocker | [EPC] | 1 |
N0000194005 | Neonatal Fc Receptor Blockers | [MoA] | 1 |
N0000191728 | Neprilysin Inhibitor | [EPC] | 5 |
N0000191727 | Neprilysin Inhibitors | [MoA] | 5 |
M0328210 | Nerve Growth Factor | [CS] | 1 |
N0000175524 | Neuraminidase Inhibitor | [EPC] | 96 |
N0000175436 | Neuraminidase Inhibitors | [MoA] | 96 |
N0000194006 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator | [EPC] | 4 |
N0000010262 | Neurokinin 1 Antagonists | [MoA] | 53 |
N0000175731 | Neuromuscular Blockade | [PE] | 246 |
N0000193962 | Neuromuscular Blocker | [EPC] | 26 |
N0000175733 | Neuromuscular Depolarizing Blockade | [PE] | 46 |
N0000175732 | Neuromuscular Nondepolarizing Blockade | [PE] | 117 |
M0014836 | Nicotine | [CS] | 703 |
N0000175594 | Nicotinic Acid | [EPC] | 68 |
M0014839 | Nicotinic Acids | [CS] | 68 |
N0000175415 | Nitrate Vasodilator | [EPC] | 300 |
M0014874 | Nitrates | [CS] | 300 |
N0000175494 | Nitrofuran Antibacterial | [EPC] | 238 |
M0014892 | Nitrofurans | [CS] | 164 |
N0000175807 | Nitrogen Binding Agent | [EPC] | 120 |
M0014901 | Nitrogen Mustard Compounds | [CS] | 1 |
N0000175435 | Nitroimidazole Antimicrobial | [EPC] | 203 |
M0014907 | Nitroimidazoles | [CS] | 203 |
N0000020015 | NMDA Receptor Antagonists | [MoA] | 140 |
N0000175745 | N-methyl-D-aspartate Receptor Antagonist | [EPC] | 140 |
N0000186106 | Noncompetitive AMPA Glutamate Receptor Antagonist | [EPC] | 10 |
N0000175720 | Nondepolarizing Neuromuscular Blocker | [EPC] | 117 |
N0000175768 | Nonergot Dopamine Agonist | [EPC] | 303 |
N0000175796 | Non-narcotic Antitussive | [EPC] | 159 |
N0000009948 | Non-Nucleoside Reverse Transcriptase Inhibitors | [MoA] | 59 |
N0000185368 | Non-Standardized Animal Dander Allergenic Extract | [EPC] | 18 |
N0000185363 | Non-Standardized Animal Hair Allergenic Extract | [EPC] | 30 |
N0000185364 | Non-Standardized Animal Skin Allergenic Extract | [EPC] | 94 |
N0000185370 | Non-Standardized Chemical Allergen | [EPC] | 282 |
N0000185373 | Non-Standardized Feather Allergenic Extract | [EPC] | 42 |
N0000185371 | Non-Standardized Food Allergenic Extract | [EPC] | 1735 |
N0000185372 | Non-Standardized Fungal Allergenic Extract | [EPC] | 590 |
N0000185374 | Non-Standardized House Dust Allergenic Extract | [EPC] | 18 |
N0000185365 | Non-Standardized Insect Allergenic Extract | [EPC] | 87 |
N0000185366 | Non-Standardized Insect Venom Allergenic Extract | [EPC] | 19 |
N0000185375 | Non-Standardized Plant Allergenic Extract | [EPC] | 1621 |
N0000185376 | Non-Standardized Plant Fiber Allergenic Extract | [EPC] | 9 |
N0000185367 | Non-Standardized Pollen Allergenic Extract | [EPC] | 1266 |
N0000175722 | Nonsteroidal Anti-inflammatory Drug | [EPC] | 4064 |
N0000193970 | Nonsteroidal Mineralocorticoid-Receptor Antagonist | [EPC] | 2 |
N0000192563 | Norepinephrine Releasing Agent | [EPC] | 32 |
N0000175695 | Norepinephrine Reuptake Inhibitor | [EPC] | 123 |
N0000000102 | Norepinephrine Uptake Inhibitors | [MoA] | 1105 |
M0289359 | N-substituted Glycines | [CS] | 5 |
N0000175697 | N-type Calcium Channel Antagonist | [EPC] | 3 |
N0000000233 | Nucleic Acid Synthesis Inhibitors | [MoA] | 286 |
N0000175459 | Nucleoside Analog | [EXT] | 522 |
N0000175467 | Nucleoside Analog Antifungal | [EPC] | 28 |
N0000175466 | Nucleoside Analog Antiviral | [EPC] | 67 |
N0000175595 | Nucleoside Metabolic Inhibitor | [EPC] | 249 |
N0000009947 | Nucleoside Reverse Transcriptase Inhibitors | [MoA] | 231 |
M0015066 | Nucleosides | [CS] | 142 |
N0000185019 | Nut Proteins | [EXT] | 55 |
M0025055 | Oligonucleotides, Antisense | [CS] | 5 |
N0000175583 | Omega-3 Fatty Acid | [EPC] | 32 |
N0000175690 | Opioid Agonist | [EPC] | 1684 |
N0000175692 | Opioid Agonist/Antagonist | [EPC] | 18 |
N0000000174 | Opioid Agonists | [MoA] | 527 |
N0000175691 | Opioid Antagonist | [EPC] | 189 |
N0000000154 | Opioid Antagonists | [MoA] | 189 |
N0000191866 | Opioid mu-Receptor Agonists | [MoA] | 2 |
N0000193983 | Optical Imaging Agent | [EPC] | 3 |
N0000191000 | Orexin Receptor Antagonist | [EPC] | 9 |
N0000190998 | Orexin Receptor Antagonists | [MoA] | 9 |
N0000190110 | Organic Anion Transporter 1 Inhibitors | [MoA] | 25 |
N0000190111 | Organic Anion Transporter 3 Inhibitors | [MoA] | 27 |
N0000190107 | Organic Anion Transporting Polypeptide 1B1 Inhibitors | [MoA] | 45 |
N0000190108 | Organic Anion Transporting Polypeptide 1B3 Inhibitors | [MoA] | 28 |
N0000190109 | Organic Anion Transporting Polypeptide 2B1 Inhibitors | [MoA] | 10 |
N0000191265 | Organic Cation Transporter 1 Inhibitors | [MoA] | 8 |
N0000187061 | Organic Cation Transporter 2 Inhibitors | [MoA] | 430 |
M0015420 | Organometallic Compounds | [CS] | 52 |
N0000193857 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor | [EPC] | 2 |
N0000010288 | Osmotic Activity | [MoA] | 2441 |
N0000175810 | Osmotic Diuretic | [EPC] | 14 |
N0000175811 | Osmotic Laxative | [EPC] | 2353 |
N0000191279 | Oxaborole Antifungal | [EPC] | 13 |
N0000175495 | Oxazolidinone Antibacterial | [EPC] | 43 |
M0361132 | Oxazolidinones | [CS] | 43 |
N0000175545 | Oxidation-Reduction Activity | [MoA] | 26 |
N0000192516 | Oxidation-Reduction Agent | [EPC] | 26 |
N0000175828 | Oxytocic | [EPC] | 23 |
M0015703 | Oxytocin | [CS] | 23 |
N0000182142 | P2Y12 Platelet Inhibitor | [EPC] | 104 |
N0000182143 | P2Y12 Receptor Antagonists | [MoA] | 104 |
M0498157 | Papillomavirus Vaccines | [CS] | 5 |
N0000180184 | Paramagnetic Contrast Agent | [EPC] | 160 |
M0015931 | Parathyroid Hormone | [CS] | 10 |
N0000180851 | Parathyroid Hormone | [EPC] | 6 |
N0000180852 | Parathyroid Hormone Analog | [EPC] | 4 |
N0000193453 | Parathyroid Hormone-Related Peptide Analog | [EPC] | 1 |
M0150746 | Parathyroid Hormone-Related Protein | [CS] | 1 |
N0000177913 | Parenteral Iron Replacement | [EPC] | 65 |
N0000175705 | Partial Cholinergic Nicotinic Agonist | [EPC] | 30 |
N0000175702 | Partial Cholinergic Nicotinic Agonists | [MoA] | 30 |
N0000175689 | Partial Opioid Agonist | [EPC] | 152 |
N0000175688 | Partial Opioid Agonist/Antagonist | [EPC] | 3 |
N0000175685 | Partial Opioid Agonists | [MoA] | 173 |
N0000183365 | Passively Acquired Immunity | [PE] | 78 |
N0000191731 | PCSK9 Inhibitor | [EPC] | 12 |
N0000191730 | PCSK9 Inhibitors | [MoA] | 12 |
N0000181811 | Pediculicide | [EPC] | 45 |
N0000175496 | Penem Antibacterial | [EPC] | 64 |
N0000175497 | Penicillin-class Antibacterial | [EPC] | 813 |
M0016152 | Penicillins | [CS] | 809 |
N0000175596 | Peroxisome Proliferator Receptor alpha Agonist | [EPC] | 396 |
N0000180186 | Peroxisome Proliferator Receptor gamma Agonist | [EPC] | 118 |
N0000175375 | Peroxisome Proliferator-activated Receptor alpha Agonists | [MoA] | 65 |
N0000175377 | Peroxisome Proliferator-activated Receptor gamma Agonists | [MoA] | 17 |
M0016424 | Pertussis Vaccine | [CS] | 11 |
N0000191264 | P-Glycoprotein Inducers | [MoA] | 12 |
N0000185503 | P-Glycoprotein Inhibitors | [MoA] | 664 |
N0000193963 | Pharmacologic Cardiac Stress Test Agent | [EPC] | 13 |
N0000175746 | Phenothiazine | [EPC] | 553 |
M0016525 | Phenothiazines | [CS] | 553 |
M0016545 | Phenylalanine Ammonia-Lyase | [CS] | 3 |
N0000190483 | Phenylalanine Hydroxylase Activator | [EPC] | 14 |
N0000190482 | Phenylalanine Hydroxylase Activators | [MoA] | 16 |
N0000193858 | Phenylalanine Metabolizing Enzyme | [EPC] | 3 |
N0000175597 | Phosphate Binder | [EPC] | 473 |
N0000020074 | Phosphate Chelating Activity | [MoA] | 473 |
N0000175598 | Phosphodiesterase 3 Inhibitor | [EPC] | 52 |
N0000175086 | Phosphodiesterase 3 Inhibitors | [MoA] | 57 |
N0000182961 | Phosphodiesterase 4 Inhibitor | [EPC] | 21 |
N0000182960 | Phosphodiesterase 4 Inhibitors | [MoA] | 21 |
N0000175599 | Phosphodiesterase 5 Inhibitor | [EPC] | 475 |
N0000020026 | Phosphodiesterase 5 Inhibitors | [MoA] | 475 |
N0000194054 | Phosphoinositide 3-Kinase delta Inhibitors | [MoA] | 1 |
N0000010217 | Photoabsorption | [MoA] | 5 |
N0000175984 | Photoactivated Radical Generator | [EPC] | 3 |
N0000175540 | Photoenhancer | [EPC] | 2 |
N0000009801 | Photosensitizing Activity | [PE] | 5 |
M0016962 | Plant Proteins | [CS] | 1706 |
N0000192750 | Plasma Kallikrein Inhibitor | [EPC] | 4 |
N0000184175 | Plasma Volume Expander | [EPC] | 46 |
N0000175578 | Platelet Aggregation Inhibitor | [EPC] | 879 |
M0017024 | Platelet-Derived Growth Factor | [CS] | 1 |
N0000020028 | Platelet-derived Growth Factor alpha Receptor Inhibitors | [MoA] | 1 |
N0000175638 | Platelet-reducing Agent | [EPC] | 5 |
N0000175413 | Platinum-based Drug | [EPC] | 100 |
N0000175073 | Platinum-containing Compounds | [EXT] | 100 |
N0000175434 | Pleuromutilin Antibacterial | [EPC] | 1 |
M0357124 | Pneumococcal Vaccines | [CS] | 6 |
M0361653 | Poliovirus Vaccines | [CS] | 11 |
M0017130 | Pollen | [CS] | 1325 |
N0000185000 | Pollen | [Chemical/Ingredient] | 6 |
N0000191623 | Poly(ADP-Ribose) Polymerase Inhibitor | [EPC] | 22 |
N0000191622 | Poly(ADP-Ribose) Polymerase Inhibitors | [MoA] | 22 |
N0000175498 | Polyene Antifungal | [EPC] | 140 |
N0000175936 | Polyene Antimicrobial | [EPC] | 1 |
M0017172 | Polyenes | [CS] | 141 |
N0000193852 | Polymerase Acidic Endonuclease Inhibitor | [EPC] | 3 |
N0000193853 | Polymerase Acidic Endonuclease Inhibitors | [MoA] | 3 |
N0000175499 | Polymyxin-class Antibacterial | [EPC] | 409 |
M0017217 | Polymyxins | [CS] | 409 |
M0017250 | Polysaccharides, Bacterial | [CS] | 4 |
N0000175846 | Porphyrin Precursor | [EPC] | 2 |
M0017335 | Porphyrinogens | [CS] | 2 |
N0000175869 | Positron Emitting Activity | [MoA] | 8 |
N0000178378 | Potassium Binder | [EPC] | 3 |
N0000175448 | Potassium Channel Antagonists | [MoA] | 61 |
N0000192795 | Potassium Channel Blocker | [EPC] | 12 |
M0026737 | Potassium Compounds | [CS] | 805 |
N0000178377 | Potassium Ion Binding Activity | [MoA] | 3 |
N0000175600 | Potassium Salt | [EPC] | 805 |
N0000175418 | Potassium-sparing Diuretic | [EPC] | 85 |
N0000185018 | Poultry Proteins | [EXT] | 9 |
M0199111 | PPAR alpha | [CS] | 149 |
N0000000115 | Progestational Hormone Receptor Antagonists | [MoA] | 2 |
M0017672 | Progesterone | [CS] | 113 |
N0000175601 | Progesterone | [EPC] | 113 |
N0000191263 | Progesterone Agonist/Antagonist | [EPC] | 4 |
M0447349 | Progesterone Congeners | [CS] | 244 |
N0000175602 | Progestin | [EPC] | 244 |
N0000175841 | Progestin Antagonist | [EPC] | 2 |
N0000175832 | Progestin-containing Intrauterine System | [EPC] | 14 |
N0000193337 | Programmed Death Ligand-1 Antagonists | [MoA] | 3 |
N0000193338 | Programmed Death Ligand-1 Blocker | [EPC] | 3 |
N0000193336 | Programmed Death Ligand-1-directed Antibody Interactions | [MoA] | 3 |
N0000191260 | Programmed Death Receptor-1 Blocking Antibody | [EPC] | 10 |
N0000191259 | Programmed Death Receptor-1-directed Antibody Interactions | [MoA] | 10 |
N0000192339 | Prostacyclin Receptor Agonist | [EPC] | 9 |
N0000020068 | Prostacyclin Receptor Agonists | [MoA] | 9 |
N0000175603 | Prostacycline | [EPC] | 2 |
N0000175416 | Prostacycline Vasodilator | [EPC] | 48 |
N0000175454 | Prostaglandin Analog | [EPC] | 83 |
N0000180189 | Prostaglandin E1 Agonist | [EPC] | 14 |
N0000175785 | Prostaglandin E1 Analog | [EPC] | 57 |
N0000194041 | Prostaglandin E2 Receptor Agonist | [EPC] | 1 |
N0000194042 | Prostaglandin E2 Receptor Agonists | [MoA] | 1 |
N0000000106 | Prostaglandin Receptor Agonists | [MoA] | 20 |
M0017805 | Prostaglandins | [CS] | 83 |
M0017811 | Prostaglandins E, Synthetic | [CS] | 57 |
M0017817 | Prostaglandins I | [CS] | 50 |
N0000175889 | Protease Inhibitor | [EPC] | 77 |
N0000175604 | Proteasome Inhibitor | [EPC] | 36 |
N0000175075 | Proteasome Inhibitors | [MoA] | 36 |
N0000175076 | Protein Kinase Inhibitors | [MoA] | 236 |
N0000000150 | Protein Synthesis Inhibitors | [MoA] | 54 |
N0000175525 | Proton Pump Inhibitor | [EPC] | 970 |
N0000000147 | Proton Pump Inhibitors | [MoA] | 970 |
N0000175909 | Provitamin D2 Compound | [EPC] | 55 |
N0000175879 | Psoralen | [EPC] | 2 |
M0017973 | Psoralens | [CS] | 2 |
N0000175712 | Purine Antimetabolite | [EPC] | 35 |
M0018169 | Purines | [CS] | 30 |
M0018228 | Pyrethrins | [CS] | 23 |
N0000175847 | Pyrethroid | [EPC] | 23 |
M0018233 | Pyridines | [CS] | 137 |
N0000191420 | Pyridone | [EPC] | 46 |
M0018236 | Pyridones | [CS] | 46 |
N0000191809 | Pyrimidine Analog | [EPC] | 2 |
N0000185502 | Pyrimidine Synthesis Inhibitor | [EPC] | 46 |
N0000007587 | Pyrimidines | [Chemical/Ingredient] | 2 |
N0000175469 | Pyrophosphate Analog | [EXT] | 8 |
N0000175470 | Pyrophosphate Analog DNA Polymerase Inhibitor | [EPC] | 8 |
M0474216 | Quaternary Ammonium Compounds | [CS] | 3 |
N0000175937 | Quinolone Antimicrobial | [EPC] | 272 |
M0023650 | Quinolones | [CS] | 272 |
N0000187053 | Radioactive alpha-Particle Emitting Therapeutic Agent | [EPC] | 1 |
N0000177914 | Radioactive Diagnostic Agent | [EPC] | 89 |
N0000175872 | Radioactive Therapeutic Agent | [EPC] | 3 |
M0018403 | Radioactive Tracers | [CS] | 1 |
N0000180185 | Radiographic Contrast Agent | [EPC] | 125 |
N0000194016 | Radioligand Activity | [MoA] | 1 |
N0000194017 | Radioligand Therapeutic Agent | [EPC] | 1 |
N0000000205 | Radiopharmaceutical Activity | [MoA] | 90 |
N0000187054 | RANK Ligand Blocking Activity | [MoA] | 2 |
N0000187055 | RANK Ligand Inhibitor | [EPC] | 2 |
N0000193947 | Rearranged during Transfection (RET) Inhibitors | [MoA] | 3 |
N0000020000 | Receptor Tyrosine Kinase Inhibitors | [MoA] | 15 |
M0018640 | Recombinant Fusion Proteins | [CS] | 4 |
N0000175958 | Recombinant Human Deoxyribonuclease 1 | [EPC] | 1 |
N0000175606 | Recombinant Human Growth Hormone | [EPC] | 51 |
N0000193854 | Recombinant Human Nerve Growth Factor | [EPC] | 1 |
M0018641 | Recombinant Proteins | [CS] | 1 |
N0000175898 | Reducing and Complexing Thiol | [EPC] | 5 |
N0000175547 | Reduction Activity | [MoA] | 35 |
N0000175514 | Renal Dehydropeptidase Inhibitor | [EPC] | 9 |
N0000175900 | Renin Inhibitor | [EPC] | 10 |
N0000175899 | Renin Inhibitors | [MoA] | 10 |
N0000175716 | Respiratory Stimulant | [EPC] | 2 |
N0000175623 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody | [EPC] | 4 |
N0000175607 | Retinoid | [EPC] | 246 |
M0018962 | Retinoids | [CS] | 246 |
N0000175982 | Reversed Anticoagulation Activity | [PE] | 37 |
N0000193788 | Rho Kinase Inhibitor | [EPC] | 2 |
N0000193789 | Rho Kinase Inhibitors | [MoA] | 2 |
N0000175500 | Rifamycin Antibacterial | [EPC] | 35 |
N0000175501 | Rifamycin Antimycobacterial | [EPC] | 10 |
M0019113 | Rifamycins | [CS] | 45 |
N0000191258 | RNA Replicase Inhibitors | [MoA] | 15 |
N0000175515 | RNA Synthetase Inhibitor Antibacterial | [EPC] | 40 |
N0000175516 | RNA Synthetase Inhibitors | [MoA] | 40 |
M0406100 | RNA, Small Interfering | [CS] | 2 |
M0357125 | Rotavirus Vaccines | [CS] | 2 |
M0019294 | Rubella Vaccine | [CS] | 3 |
M0515971 | Salivary Proteins and Peptides | [CS] | 21 |
N0000193948 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor | [EPC] | 2 |
N0000020024 | Sclerosing Activity | [MoA] | 3 |
N0000175814 | Sclerosing Agent | [EPC] | 3 |
N0000006078 | Secretin | [Chemical/Ingredient] | 3 |
N0000175813 | Secretin-class Hormone | [EPC] | 3 |
M0516536 | Seed Storage Proteins | [CS] | 912 |
N0000000168 | Selective Estrogen Receptor Modulators | [MoA] | 84 |
N0000191262 | Selective Progesterone Receptor Modulators | [MoA] | 4 |
N0000182830 | Selective T Cell Costimulation Blocker | [EPC] | 1 |
N0000182159 | Selective T Cell Costimulation Modulator | [EPC] | 4 |
N0000175763 | Serotonin 1b Receptor Agonists | [MoA] | 286 |
N0000175764 | Serotonin 1d Receptor Agonists | [MoA] | 286 |
N0000175817 | Serotonin 3 Receptor Antagonists | [MoA] | 345 |
N0000193870 | Serotonin 4 Receptor Agonists | [MoA] | 2 |
N0000175749 | Serotonin and Norepinephrine Reuptake Inhibitor | [EPC] | 651 |
N0000175696 | Serotonin Reuptake Inhibitor | [EPC] | 1066 |
N0000000109 | Serotonin Uptake Inhibitors | [MoA] | 1574 |
N0000175765 | Serotonin-1b and Serotonin-1d Receptor Agonist | [EPC] | 286 |
N0000175818 | Serotonin-3 Receptor Antagonist | [EPC] | 345 |
N0000193871 | Serotonin-4 Receptor Agonist | [EPC] | 2 |
N0000169504 | Serum Albumin | [Chemical/Ingredient] | 29 |
N0000185020 | Shellfish Proteins | [EXT] | 15 |
N0000182149 | Sigma-1 Agonist | [EPC] | 2207 |
N0000182147 | Sigma-1 Receptor Agonists | [MoA] | 2207 |
M0053814 | Silk | [CS] | 4 |
N0000175738 | Skeletal Muscle Relaxant | [EPC] | 29 |
N0000010282 | Skin Barrier Activity | [PE] | 761 |
N0000184316 | Skin Test Antigen | [EPC] | 15 |
N0000192337 | SLAMF7-directed Antibody Interactions | [MoA] | 2 |
N0000192338 | SLAMF7-directed Immunostimulatory Antibody | [EPC] | 2 |
N0000193848 | Small Interfering RNA | [EPC] | 2 |
M0019978 | Smallpox Vaccine | [CS] | 14 |
N0000184148 | Smoothened Receptor Antagonists | [MoA] | 4 |
N0000181004 | Sodium Channel Antagonists | [MoA] | 4 |
N0000187059 | Sodium-Glucose Cotransporter 2 Inhibitor | [EPC] | 57 |
N0000187058 | Sodium-Glucose Transporter 2 Inhibitors | [MoA] | 57 |
N0000194056 | Sodium-Hydrogen Exchanger 3 Inhibitor | [EPC] | 3 |
N0000194057 | Sodium-Hydrogen Exchanger 3 Inhibitors | [MoA] | 3 |
N0000190485 | Soluble Guanylate Cyclase Stimulator | [EPC] | 8 |
N0000175904 | Somatostatin Analog | [EPC] | 42 |
N0000000194 | Somatostatin Receptor Agonists | [MoA] | 42 |
N0000181816 | Sphingosine 1-phosphate Receptor Modulator | [EPC] | 24 |
N0000181815 | Sphingosine 1-Phosphate Receptor Modulators | [MoA] | 24 |
N0000185003 | Standardized Animal Hair Allergenic Extract | [EPC] | 20 |
N0000185004 | Standardized Animal Skin Allergenic Extract | [EPC] | 3 |
N0000185508 | Standardized Chemical Allergen | [EPC] | 1031 |
N0000185005 | Standardized Insect Allergenic Extract | [EPC] | 30 |
N0000185021 | Standardized Insect Venom Allergenic Extract | [EPC] | 406 |
N0000185006 | Standardized Pollen Allergenic Extract | [EPC] | 105 |
M0020435 | Starch | [CS] | 4 |
N0000020034 | Stem Cell Factor (KIT) Receptor Inhibitors | [MoA] | 1 |
M0004273 | Sterol Esterase | [CS] | 1 |
N0000175812 | Stimulant Laxative | [EPC] | 149 |
N0000009871 | Stimulation Large Intestine Fluid/Electrolyte Secretion | [PE] | 1372 |
N0000175786 | Substance P/Neurokinin-1 Receptor Antagonist | [EPC] | 53 |
N0000175819 | Sucrose-specific Enzyme | [EPC] | 1 |
N0000175503 | Sulfonamide Antibacterial | [EPC] | 154 |
N0000175504 | Sulfonamide Antimicrobial | [EPC] | 108 |
M0020790 | Sulfonamides | [CS] | 384 |
N0000175881 | Sulfone | [EPC] | 32 |
M0020791 | Sulfones | [CS] | 32 |
N0000175608 | Sulfonylurea | [EPC] | 396 |
M0020795 | Sulfonylurea Compounds | [CS] | 396 |
N0000175778 | Surfactant | [EPC] | 2 |
N0000000079 | Surfactant Activity | [MoA] | 2 |
N0000193222 | Survival Motor Neuron-2-directed RNA Interaction | [EPC] | 1 |
N0000194059 | Survival of Motor Neuron 2 Splicing Modifier | [EPC] | 1 |
N0000194060 | Survival of Motor Neuron 2 Splicing Modifiers | [MoA] | 1 |
N0000175423 | Sympathomimetic Amine Anorectic | [EPC] | 204 |
N0000175769 | Sympathomimetic-like Agent | [EPC] | 45 |
N0000182829 | T Lymphocyte Costimulation Activity Blockade | [PE] | 1 |
N0000193548 | T Lymphocytes, Cultured, Autologous, Genetically-modified | [EXT] | 3 |
M0021204 | Tetanus Toxoid | [CS] | 21 |
N0000175938 | Tetracycline-class Antibacterial | [EPC] | 12 |
N0000175505 | Tetracycline-class Antimicrobial | [EPC] | 46 |
N0000175882 | Tetracycline-class Drug | [EPC] | 509 |
M0021223 | Tetracyclines | [CS] | 567 |
N0000184014 | Thalidomide Analog | [EPC] | 80 |
N0000175419 | Thiazide Diuretic | [EPC] | 913 |
N0000175420 | Thiazide-like Diuretic | [EPC] | 172 |
M0471776 | Thiazides | [CS] | 913 |
N0000180190 | Thiazolidinedione | [EPC] | 118 |
M0447306 | Thiazolidinediones | [CS] | 118 |
N0000009963 | Thrombin Inhibitors | [MoA] | 54 |
N0000175973 | Thrombopoietin Receptor Agonist | [EPC] | 9 |
N0000175968 | Thrombopoietin Receptor Agonists | [MoA] | 9 |
N0000194010 | Thymic Stromal Lymphopoietin Blocker | [EPC] | 3 |
N0000194011 | Thymic Stromal Lymphopoietin Blockers | [MoA] | 3 |
N0000191870 | Thymidine Phosphorylase Inhibitor | [EPC] | 2 |
N0000191869 | Thymidine Phosphorylase Inhibitors | [MoA] | 2 |
N0000175918 | Thyroid Hormone Synthesis Inhibitor | [EPC] | 42 |
N0000175917 | Thyroid Hormone Synthesis Inhibitors | [MoA] | 42 |
N0000175949 | Thyroid Stimulating Hormone | [EPC] | 3 |
M0021496 | Thyrotropin | [CS] | 3 |
M0021504 | Thyroxine | [CS] | 557 |
N0000191865 | Tissue-nonspecific Alkaline Phosphatase | [EPC] | 4 |
N0000175609 | Topoisomerase Inhibitor | [EPC] | 56 |
N0000000176 | Topoisomerase Inhibitors | [MoA] | 144 |
N0000193849 | Transthyretin-directed RNA Interaction | [EPC] | 3 |
N0000175752 | Tricyclic Antidepressant | [EPC] | 748 |
M0021969 | Triglycerides | [CS] | 1 |
M0021977 | Triiodothyronine | [CS] | 81 |
M0022020 | Triterpenes | [CS] | 1 |
N0000193966 | Triterpenoid Antifungal | [EPC] | 1 |
N0000193859 | Tropomyosin Receptor Kinases Inhibitors | [MoA] | 7 |
N0000000197 | Trypsin Inhibitors | [MoA] | 2 |
N0000193303 | Tryptophan Hydroxylase Inhibitor | [EPC] | 3 |
N0000193302 | Tryptophan Hydroxylase Inhibitors | [MoA] | 3 |
N0000184315 | Tuberculosis Skin Test | [EPC] | 14 |
N0000175848 | Tubulin Inhibiting Agent | [EPC] | 22 |
N0000175610 | Tumor Necrosis Factor Blocker | [EPC] | 60 |
N0000175451 | Tumor Necrosis Factor Receptor Blocking Activity | [MoA] | 60 |
N0000193967 | Type I Interferon Receptor Antagonist | [EPC] | 1 |
N0000193968 | Type I Interferon Receptor Antagonists | [MoA] | 1 |
N0000180182 | Typical Antipsychotic | [EPC] | 186 |
N0000020001 | Tyrosine Kinase Inhibitors | [MoA] | 15 |
N0000190117 | UDP Glucuronosyltransferases Inducers | [MoA] | 21 |
N0000191269 | UDP Glucuronosyltransferases Inhibitors | [MoA] | 35 |
N0000191272 | UGT1A1 Inhibitors | [MoA] | 46 |
N0000191275 | UGT1A3 Inhibitors | [MoA] | 6 |
N0000191276 | UGT1A4 Inhibitors | [MoA] | 6 |
N0000191277 | UGT1A6 Inhibitors | [MoA] | 6 |
N0000191278 | UGT1A9 Inhibitors | [MoA] | 19 |
N0000191274 | UGT2B15 Inhibitors | [MoA] | 6 |
N0000191273 | UGT2B7 Inhibitors | [MoA] | 19 |
N0000010259 | Ultrasound Contrast Activity | [MoA] | 5 |
N0000181819 | Uncompetitive NMDA Receptor Antagonists | [MoA] | 2207 |
N0000181821 | Uncompetitive N-methyl-D-aspartate Receptor Antagonist | [EPC] | 2207 |
N0000175474 | Unfractionated Heparin | [EPC] | 127 |
M0022307 | Urate Oxidase | [CS] | 1 |
M0022315 | Urea | [CS] | 23 |
N0000175611 | Urease Inhibitor | [EPC] | 1 |
N0000175087 | Urease Inhibitors | [MoA] | 1 |
N0000175670 | Uric Acid-specific Enzyme | [EPC] | 1 |
M0022454 | Vaccines, Attenuated | [CS] | 10 |
N0000170873 | Vaccines, Attenuated | [Chemical/Ingredient] | 2 |
M0027265 | Vaccines, Conjugate | [CS] | 4 |
M0023305 | Vaccines, Inactivated | [CS] | 66 |
M0569003 | Vaccines, Live, Unattenuated | [CS] | 15 |
M0022188 | Vaccines, Typhoid | [CS] | 4 |
N0000193543 | Vascular Endothelial Growth Factor Inhibitor | [EPC] | 21 |
N0000193542 | Vascular Endothelial Growth Factor Inhibitors | [MoA] | 21 |
N0000191009 | Vascular Endothelial Growth Factor Receptor 2 Antagonist | [EPC] | 2 |
N0000178291 | Vascular Endothelial Growth Factor-directed Antibody Interactions | [MoA] | 10 |
N0000009905 | Vascular Sclerosing Activity | [PE] | 3 |
N0000009908 | Vasoconstriction | [PE] | 208 |
N0000192562 | Vasoconstrictor | [EPC] | 199 |
N0000009909 | Vasodilation | [PE] | 418 |
N0000175940 | Vasodilator | [EPC] | 72 |
N0000175905 | Vasopressin Analog | [EPC] | 57 |
N0000193181 | Vasopressin V2 Receptor Antagonist | [EPC] | 17 |
N0000193178 | Vasopressin V2 Receptor Antagonists | [MoA] | 17 |
M0022562 | Vasopressins | [CS] | 66 |
M0022575 | Vegetable Proteins | [CS] | 496 |
N0000020032 | VEGFR2 Inhibitors | [MoA] | 2 |
N0000184010 | Venom Neutralization | [MoA] | 2 |
N0000009911 | Venous Vasodilation | [PE] | 14 |
N0000190856 | Vesicular Monoamine Transporter 2 Inhibitor | [EPC] | 27 |
N0000190855 | Vesicular Monoamine Transporter 2 Inhibitors | [MoA] | 27 |
N0000175612 | Vinca Alkaloid | [EPC] | 5 |
M0022674 | Vinca Alkaloids | [CS] | 5 |
N0000184009 | Virus Neutralization | [MoA] | 11 |
N0000184152 | Virus-specific Hyperimmune Globulins | [EXT] | 11 |
M0022788 | Vitamin A | [CS] | 82 |
N0000175950 | Vitamin A | [EPC] | 82 |
M0022794 | Vitamin B 12 | [CS] | 143 |
N0000005657 | Vitamin B 6 | [Chemical/Ingredient] | 154 |
M0022792 | Vitamin B Complex | [CS] | 4 |
N0000175714 | Vitamin B Complex Member | [EPC] | 4 |
N0000175951 | Vitamin B12 | [EPC] | 143 |
N0000192800 | Vitamin B6 Analog | [EPC] | 154 |
N0000193618 | Vitamin C | [EPC] | 188 |
N0000175952 | Vitamin D | [EPC] | 104 |
M0022797 | Vitamin D | [CS] | 137 |
N0000175849 | Vitamin D Analog | [EPC] | 35 |
N0000175907 | Vitamin D2 Analog | [EPC] | 54 |
N0000175908 | Vitamin D3 Analog | [EPC] | 62 |
M0022806 | Vitamin K | [CS] | 33 |
N0000180191 | Vitamin K | [EPC] | 33 |
N0000175476 | Vitamin K Antagonist | [EPC] | 179 |
N0000175964 | Vitamin K Inhibitors | [MoA] | 179 |
M0022850 | von Willebrand Factor | [CS] | 1 |
N0000175966 | Warfarin Reversal Agent | [EPC] | 33 |
M0022877 | Wasp Venoms | [CS] | 6 |
N0000175698 | Xanthine Oxidase Inhibitor | [EPC] | 182 |
N0000000206 | Xanthine Oxidase Inhibitors | [MoA] | 182 |
M0023046 | Xanthines | [CS] | 578 |
N0000010258 | X-Ray Contrast Activity | [MoA] | 121 |
M0357360 | Yellow Fever Vaccine | [CS] | 2 |